ข้ามไปยังเนื้อหา
Merck

AMPD1

DNase I

Amplification Grade

Synonym(s):

Deoxyribonuclease I

เข้าสู่ระบบ เพื่อดูราคาสำหรับองค์กรและสัญญา

เลือกขนาด

เปลี่ยนการดู

เกี่ยวกับสินค้านี้

หมายเลข EC:
NACRES:
NA.55
UNSPSC Code:
41106300
Concentration:
1 unit/μL
บริการทางเทคนิค
ต้องการความช่วยเหลือหรือไม่ ทีมนักวิทยาศาสตร์ที่มีประสบการณ์ของเราอยู่ที่นี่เพื่อคุณ
ให้เราช่วยเหลือ


Quality Level

form

liquid

concentration

1 unit/μL

technique(s)

RT-PCR: suitable

color

colorless

shipped in

wet ice

storage temp.

−20°C

General description

Deoxyribonuclease I (DNase I) is an endonuclease isolated from bovine pancreas that digests double and single stranded DNA into oligo and mononucleotides. Amplification Grade DNase I has been purified to remove RNase activity, and is suitable for eliminating DNA from RNA preparations prior to sensitive applications, such as RT-PCR (Reverse Transcriptase - Polymerase Chain Reaction).

DNase I digests double- and single-stranded DNA into oligo- and mononucleotides. Using the Reaction Buffer provided, DNA is removed from RNA preparations in a 15 minute digestion at room temperature. The DNase I is then inactivated by heating with the Stop Solution. Heating also denatures hairpins in the RNA, so the RNA can be used directly in reverse transcription.

No current RNA isolation procedure removes 100% of the DNA. Many commercial DNase I formulations are contaminated with residual RNases. This RNase contamination can destroy or degrade valuable RNA samples prior to reverse transcription. Laboratory comparisons have shown that Sigma′s Amplification Grade DNase I demonstrates lower RNase activity than that from several leading molecular biology product suppliers.
No current RNA isolation procedure removes 100% of the DNA. Many commercial DNase I formulations are contaminated with residual RNases. This RNase contamination can destroy or degrade valuable RNA samples prior to reverse transcription. Laboratory comparisons have shown that Sigma′s Amplification Grade DNase I demonstrates lower RNase activity than that from several leading molecular biology product suppliers.

Application

Suitable for use in removing DNA from RNA preparations.
Amplification grade DNase I has been used:
  • for the digestion of DNA during isolation and purification of RNA. The purified RNA can be used for the synthesis of cDNA using RNA reverse transcriptase.
  • to hydrolyze extracellular matrix (ECM) components and enhance photosensitizer penetration into the biofilm to determine the efficacy of antimicrobial photodynamic therapy (aPDT) on Candida albicans biofilms
  • to remove contaminating DNA from total RNA extracted from cattle blood samples

Features and Benefits

  • Suitable for the elimination of DNA from RNA
  • Minimal RNase activity available
  • Optimized 10× reaction buffer and Stop Solution for complete inactivation of DNase I

Other Notes

One unit completely digests 1 μg of plasmid DNA to oligonucleotides in 10 min. at 37 °C.

Legal Information

Purchase of this product is accompanied by a limited license for use in the Polymerase Chain Reaction (PCR) process for research purposes only and in conjunction with a thermal cycler whose use in the automated performance of the PCR process is covered by an up-front license fee, either by payment to Applied Biosystems or as purchased, i.e., and authorized thermal cycler.


ยังไม่พบสินค้าที่ใช่ใช่หรือไม่?

สำรวจสินค้าทั้งหมดของเราภายใต้ DNase I


คลาสการจัดเก็บ

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable



เลือกจากเวอร์ชันล่าสุด:

ใบรับรองผลการวิเคราะห์ (COA)

หมายเลขล็อต/ชุด

ไม่เห็นเวอร์ชันที่ถูกต้องใช่หรือไม่?

หากต้องการเวอร์ชันเฉพาะ สามารถค้นหาใบรับรองเฉพาะได้โดยใช้หมายเลขล็อตหรือชุดของสินค้า

มีผลิตภัณฑ์นี้อยู่แล้วใช่หรือไม่?

ค้นหาเอกสารข้อมูลสำหรับผลิตภัณฑ์ที่คุณเพิ่งซื้อได้ในคลังเอกสาร

ดูห้องสมุดเอกสาร


โปรโตคอล

Method for reverse transcription of RNA into DNA. Uses a premixed reagent that contains reverse transcriptase, dNTPs, primers, RNase inhibitor and buffer. Fast generation of cDNA.

The SeqPlex RNA Amplification kit provides a method for amplification of total RNA or isolated mRNA prior to entry into the workflows of the commonly used deep sequencing platforms.

บทความ

SeqPlex™-I WTA kit amplifies RNA for NGS, enabling genomic studies from limited samples.

Use of MULTI-seq lipid-modified oligos, protocol, and troubleshooting guide for PCR Assays and Sequencing applications.

Understand how mRNA vaccines induce immunity. and read how synthetic mRNA is prepared for vaccine immunogens and other biopharmaceuticals. Find reagents for synthesis of mRNA.

เนื้อหาที่เกี่ยวข้อง

KOD One™ PCR Master Mix overview for ultra-fast PCR with high specificity, fidelity, and yield

ปฏิกิริยาลูกโซ่โพลีเมอเรส (PCR) เป็นเทคนิคสำหรับการขยายโมเลกุลของกรดนิวคลีอิกและมักใช้ในการใช้งานหลายอย่างรวมถึง RT-PCR, PCR เริ่มต้นร้อน, PCR จุดสิ้นสุดและอื่นๆ

Polymerase chain reaction (PCR) is a technique for amplifying nucleic acid molecules and is commonly used in many applications, including RT-PCR, hot start PCR, end point PCR and more.

ดูเนื้อหาที่เกี่ยวข้องทั้งหมด

Ling Yuan et al.
Molecular vision, 18, 1684-1695 (2012-07-10)
The objectives of this study were to determine whether high-glucose-induced upregulation of heparanase (HPSE) expression and differential heparanase expression in human retinal vascular endothelial cells (HRECs) can alter HREC migration and proliferation. We also aimed to determine whether HREC migration
John P Dunbar et al.
Toxins, 12(6) (2020-06-24)
The noble false widow spider Steatoda nobilis originates from the Macaronesian archipelago and has expanded its range globally. Outside of its natural range, it may have a negative impact on native wildlife, and in temperate regions it lives in synanthropic
Hafid Ait-Oufella et al.
The Journal of experimental medicine, 207(8), 1579-1587 (2010-07-07)
B cell depletion significantly reduces the burden of several immune-mediated diseases. However, B cell activation has been until now associated with a protection against atherosclerosis, suggesting that B cell-depleting therapies would enhance cardiovascular risk. We unexpectedly show that mature B